Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Infectious diseases 5

Infectious Diseases

Pharma News and Updates for Akero Chiesi Pfizer

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca’s Danicopan Trial; CHMP Recommends Sanofi/AstraZeneca’s nirsevimab; Akero’s NASH Drug Trial; FDA Grants Orphan Drug Status to SY-5609; BMS’s Opdivo Trial Results; Pfizer to File for FDA Approval for Meningitis Vaccine; EMA Orphan Drug Designation to CAN-2409; FDA Starts Priority Review of Chiesi ‘s velmanase alfa

AstraZeneca’s Danicopan Shows Positive Results in Phase III Trial Danicopan, an oral Factor D inhibitor developed by AstraZeneca, was expected to fail a phase II trial in rare kidney disease in 2020, but a new readout could revive the drug. Danicopan (ALXN2040) has demonstrated efficacy as an adjunct treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) who have extravascular hemolysis (EVH) - the breakdown of red blood cells in the spleen, bone marrow, or liver. The drug is being developed for use in PNH in combination with Alexion's established C5 inhibitor therapies Soliris (eculizumab) and Ultomiris (ravulizumab), as well as for eye disease geog...

Explore More...

medtech-news-for-lensgen-ge-nevro-hyperfine-immunexpress

LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to Immunexpress’s SeptiCyte; GE unveils AI and Digital Technologies; Canon launches PIQE DLR and SilverBeam; Hyperfine’s Swoop gets FDA clearance

pharma-news-for-ge-optellum-therapixel-ocugen-blueprint

GE Healthcare-Optellum’s collaboration; Ocugen’s Covid-19 vaccine trial; Blueprint to acquire Lengo Therapeutics; Therapixel’s Mammoscreen

pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares

Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Heptares; FDA opens clearances for hepatitis C diagnostics; Twist nabs antibody discovery biotech Abveris for $190M

HIV-Therapeutics-Market-drugs-companies-epidemiology-population

Top Drugs To Watch in HIV (2025)

medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign

Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies’s Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic

covid-19-and-the-social-determinants-of-health

Social Determinants of Health and their Impact on COVID-19

HIV-1-treatment-market

Changing Dynamics of HIV-1 Treatment Market

medtech-news-for-naviswiss-allosource-spinafx-starfish-smith-nephew

FDA 510k clearance to Naviswiss’s Naviplan; FDA approved to TYRVAYA; Centinel Spine’s STALIF Integrated Interbody System; Smith+Nephew’s IODOSORB; AlloSource’s AlloMend Extra-Large ADM; SpinaFX and StarFish’s strategic commercialisation contract

Probiotics Market

Analyzing the Emerging Demand for the Probiotics

pharma-biotech-news-updates-for-biogen-smartlabs-synlogic-partner-therapeutics

Biogen’s AMD Biosimilar Gets Approval; SmartLabs Series B Funding; BARDA, Partner Therapeutics in Sepsis Space; Synlogic to Explore Sepsis Market Domain

onychomycosis-market-CAGR-size-share-trends-growth-population-epidemiology-therapy-therapeutics-treatment

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Continue to Adorn the Space

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

venous-thromboembolism-market-size-share-trends-companies-cagr-growth-therapy-treatment-therapeutics

Venous Thromboembolism Market Growth Quadrant to Balloon Up

recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo

AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers Squibb’s Opdivo; and Masimo’s PVi

Latest-pharma-biotech-news-updates-for-gsk-pfizer-biontech-biovac-seres-therapeutics

Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial

uncomplicated-urinary-tract-infections-market

Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly